|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 35/761 | (2015.01) | ||
| C07K 14/535 | (2006.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61K 39/00 | (2006.01) |
| (11) | Number of the document | 3293201 |
| (13) | Kind of document | T |
| (96) | European patent application number | 16188301.2 |
| Date of filing the European patent application | 2016-09-12 | |
| (97) | Date of publication of the European application | 2018-03-14 |
| (45) | Date of publication and mention of the grant of the patent | 2020-11-04 |
| (46) | Date of publication of the claims translation | 2021-03-25 |
| (72) |
RANKI, Tuuli, FI
PESONEN, Sari, FI
JÄDERBERG, Magnus, GB
HAAVISTO, Elina, FI
KURYK, Lukasz, FI
VUOLANTO, Antti, FI
|
| (73) |
Targovax Oy,
Lars Sonckin kaari 14, 02600 Espoo,
FI
|
| (74) |
Reda ŽABOLIENĖ,
METIDA, Verslo centras "VERTAS", Gynėjų g. 16, LT-01109 Vilnius,
LT
|
| (54) | Adenoviruso ir kontrolinio taško inhibitoriaus derinys vėžio gydymui |
| COMBINING ADENOVIRUS AND CHECKPOINT INHIBITORS FOR TREATING CANCER |
| Payment date | Validity (years) | Amount | |
| 2023-08-25 | 8 | 185.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2024-09-12 |